mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.21 |
0.0006 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0006 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0007 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0008 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0008 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0009 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0009 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.001 |